Results 91 to 100 of about 447,312 (181)
Modern View on the Pathogenetic Therapy of Diabetic Polyneuropathy
The article deals with the treatment of diabetic polyneuropathy (DPN) using Actovegin. The results of research on the effectiveness of this drug in 200 patients with diabetes mellitus (aged from 19 to 88 years) are provided.
N.O. Pertseva, I.N. Mikhailinchik
doaj +1 more source
ABSTRACT Aim The Rotterdam Diabetic Foot (RDF) Test Battery was developed to assess sensory function and predict the risk of diabetic foot ulceration and falls. We evaluated its interobserver reliability in patients with diabetic sensorimotor polyneuropathy. Methods The RDF Test Batteries include a continuous and dichotomous 39‐item scale and a shorter
Nadine Boers +5 more
wiley +1 more source
Complication prevention in Type 2 diabetes across the life course. The visual abstract summarises a life‐course approach to complication prevention in Type 2 diabetes. Cumulative metabolic exposure represents the burden carried forward from previous glycaemic, blood‐pressure, lipid and adiposity‐related exposure; organ vulnerability identifies the ...
Ferenc Sztanek
wiley +1 more source
The influence of physiotherapy on stability disorders in patients with diabetic polyneuropathy [PDF]
The influence of physiotherapy on stability disorders in patients with diabetic polyneuropathy Powered by TCPDF (www.tcpdf ...
Judlová, Tereza
core
Consensus Guidelines for Diagnosis and Management of Pyruvate Dehydrogenase Complex Deficiency
ABSTRACT Primary pyruvate dehydrogenase complex deficiency (PDCD) comprises a group of monogenic disorders caused by pathogenic variants in genes encoding subunits of, or regulatory components affecting, the pyruvate dehydrogenase complex. The clinical phenotype spans a broad continuum, ranging from early onset congenital lactic acidosis to infantile ...
Nandaki Keshavan +23 more
wiley +1 more source
Evaluation of Topiramate Efficacy on Neuropathic Pain in Patients With Diabetic Polyneuropathy
Polyneuropathy is one of the most common and disabling complications of diabetes. Severe pain is one of the complications of diabetic polyneuropathy .Over the years, many drugs for the treatment of the pain in diabetic neuropathy have been tried. However,
Sedigheh Shamsinejad +4 more
doaj
Diabetics have higher risks of osteoporosis, falls, and fractures; higher grip strength predicts lower risks. In both cross‐sectional and longitudinal data, diabetic patients with both peripheral neuropathy and low appendicular muscle mass have the highest risks of osteoporosis and falls.
Biao Zheng +6 more
wiley +1 more source
Objective: To determine the frequency of peripheral polyneuropathy in patients having diabetes mellitus with symptoms of polyneuropathy using electrodiagnostic procedure.
Sahibzada Nasir Mansoor +4 more
doaj +2 more sources
ABSTRACT Background Distal symmetrical polyneuropathy (DSPN) is a common complication of type 1 diabetes (T1D), yet validated biomarkers for early detection or prognosis are lacking. Metabolic disturbances driven by chronic hyperglycemia and dyslipidemia contribute to DSPN development and progression.
Tik Muk +18 more
wiley +1 more source
SGLT2i use and fracture risk compared with DPP4i in patients with T2DM
ABSTRACT Introduction The association between sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) use and fracture risk remains inconclusive. Most previous studies have focused on treatment‐naïve patients, despite many patients in routine clinical practice initiating SGLT2i therapy after prior dipeptidyl peptidase‐4 inhibitor (DPP4i) use.
Sung‐Yen Lin +5 more
wiley +1 more source

